We are witnessing an incredible period in human history, where innovation is developing at a pace that is difficult to fathom, and seemingly unrelated sciences are converging for the greater good. Computing, medicine, biotechnology, agriculture, AI, and machine learning are but a few of the apparently disassociated fields that are collaborating to great effect in making the world a better place.
In the field of drug development, a more accommodative regulatory environment has opened the floodgates in realizing and unleashing the incredible healing properties of cannabinoids-based treatment options for a plethora of medical needs.
Taking a drug from the concept phase through the approval stage can take years and cost billions of dollars. AI and machine learning can reduce the time and cost of this process significantly. Nevertheless, not every drug is a panacea for its intended user; especially when no two individuals have the same DNA to assimilate the treatment in questions. It’s almost like asking two people to wear the same size and style of shoes – chances are one or both aren’t going to enjoy that experience. This is much more true in relation to medical treatment. And that’s where personalized medicine comes into play.
A quick, cheap and anonymous DNA test may enable the power of cannabinoids-based treatments to be fully realized on the personal level. Following a DNA analysis, cannabinoids-based treatments that have been approved can be tailored to individuals with an incredibly high degree of accuracy according to specific dosage prescriptions and the likely side effects of the medication. This increases the likelihood of the individual attaining the optimal benefit from the medication with minimal side-effects.
The future of medicine is here. It is an exciting time to be alive, and with the help of a diverse range of sciences, this excitement should be long-lasting while entailing minimal health risks.